Skip to main content

OXB · OXFORD BIOMEDICA PLC · Financials

5.3100 GBP -0.1300 (-2.39%) At close · Oct 6
Market Cap
613.70M GBP
Shares
121.04M

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Browse captured authority reports and their original financial labels

Revenue
168.74M +31%
FY2025 Revenue FY2020–FY2025
Net Income
-30.13M +30.2%
FY2025 Net Income FY2020–FY2025
Gross Margin
39.1% -2.1pp
FY2025 Gross Margin FY2020–FY2025
Operating Margin
-13.32% +17.2pp
FY2025 Operating Margin FY2020–FY2025
Operating Cash Flow
507K +101%
FY2025 Operating Cash Flow FY2020–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
GBP 168.74M 128.8M 89.54M 139.99M 142.8M 87.73M
GBP 102.76M 75.78M 49.81M 70.81M 60.16M 41.66M
GBP 65.98M 53.02M 39.73M 69.18M 82.64M 46.07M
GBP 5.06M 4.54M 11.47M 60.94M 40.19M 29.75M
GBP 36.76M 29.42M 26.89M 28.22M 15.15M 11.26M
GBP -22.48M -39.38M -184.17M -30.22M 20.77M -5.69M
GBP 14.63M 11.13M 9.26M 16.73M 888K 912K
GBP -31.94M -47.27M -188.53M -45.98M 19.88M -6.57M
GBP -1.29M 1.34M -4.37M -817K 869K -327K
GBP -30.13M -43.19M -157.49M -39.16M 19.01M -6.25M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current borrowings, including current portion of noncurrent borrowings 2025-12-31 GBP 0 ESEF Annual Report filed 2026-04-07
Current lease liabilities 2025-12-31 GBP 6,057,000 ESEF Annual Report filed 2026-04-07
Noncurrent lease liabilities 2025-12-31 GBP 100,583,000 ESEF Annual Report filed 2026-04-07
Noncurrent long-term borrowings 2025-12-31 GBP 41,488,000 ESEF Annual Report filed 2026-04-07
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.